Let's not forget though, through China, it gets the 1.5 billion in revenue (up to), then outside China, NGIO / Generex adds to that 1.5 billion on top of that, including the 1 billion from the Malaysia deal. So, now we are talking potential more billions not just with a Covid Vaccine, but Swine Flu, Excellagen in China, Malaysia, US, etc.. and who knows what other products..

Things really open up.